Aging and bone loss: new insights for the clinician
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
It is well known that the underlying mechanisms of osteoporosis in older adults are different than those associated with estrogen deprivation. Age-related bone loss involves a gradual and progressive decline, which is also seen in men. Markedly increased bone resorption leads to the initial fall in bone mineral density. With increasing age, there is also a significant reduction in bone formation. This is mostly due to a shift from osteoblastogenesis to predominant adipogenesis in the bone marrow, which also has a lipotoxic effect that affects matrix formation and mineralization. We review new evidence on the pathophysiology of age-related bone loss with emphasis upon the mechanism of action of current osteoporosis treatments. New potential treatments are also considered, including therapeutic approaches to osteoporosis in the elderly that focus on the pathophysiology and potential reversal of adipogenic shift in bone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986 · cited 1×
“The intravenous bisphosphonate zoledronate also has fracture reduction efficacy for vertebral, hip, and nonvertebral fractures, in both men and women [Black et al. 2007; 68 http://tab.sagepub.com Lyles et al. 2007] and glucocorticoid-induced osteoporosis [Reid et al. 2009].”
BackgroundHarris, S. T. (1999) · JAMA · doi:10.1001/jama.282.14.1344 · Cited by 2,475 · cited 1×
“Similarly risedronate reduce vertebral fractures [Harris et al. 1999; Reginster et al. 2000], nonvertebral fractures [Wells et al. 2008b], hip fractures in osteoporotic older women [McClung et al. 2001], and glucocorticoid-induced osteoporosis [Reid et al. 2000].”
BackgroundChamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0197 · Cited by 2,381
Lips, P. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.4.0437 · Cited by 2,118
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003 · cited 1×
“The intravenous bisphosphonate zoledronate also has fracture reduction efficacy for vertebral, hip, and nonvertebral fractures, in both men and women [Black et al. 2007; 68 http://tab.sagepub.com Lyles et al. 2007] and glucocorticoid-induced osteoporosis [Reid et al. 2009].”
BackgroundEffect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
Riggs, B. L., & Melton, L. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606263142605 · Cited by 1,915
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., & Karsenty, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01049-8 · Cited by 1,735 · cited 1×
“Further animal studies also reported a central regulatory role of leptin [Ducy et al. 2000; Takeda et al. 2002].”
BackgroundMeunier, P. J., Roux, C., Seeman, E., Ortolani, S., Badurski, J. E., Spector, T. D., Cannata, J., Balogh, A., Lemmel, E.-M., Pors-Nielsen, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa022436 · Cited by 1,638
Reginster, J.-Y., Minne, H. W., Sorensen, O. H., Hooper, M., Roux, C., Brandi, M. L., Lund, B., Ethgen, D., Pack, S., Roumagnac, I., et al. (2000) · Osteoporosis International · doi:10.1007/s001980050010 · Cited by 1,580
Regulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407 · cited 6×
“In terms of neutralizing Wnt antagonist such as with Dkk-1 antibodies, preclinical models have shown an increase in BMD, trabecular bone volume, osteoblast surface, and bone formation in rodents [Grisanti et al. 2006].”
BackgroundInfluentialLamin a truncation in Hutchinson-Gilford progeria
De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C. L., Munnich, A., Le Merrer, M., et al. (2003) · Science · doi:10.1126/science.1084125 · Cited by 1,346
Chesnut, C. H., Skag, A., Christiansen, C., Recker, R., Stakkestad, J. A., Hoiseth, A., Felsenberg, D., Huss, H., Gilbride, J., Schimmer, R. C., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040325 · Cited by 1,229
Denosumab in postmenopausal women with low bone mineral density.
McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044459 · Cited by 1,228
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147 · cited 1×
“…mutations of the SOST gene are associated with an autosomal-recessive disorder, sclerosteosis, which causes progressive bone overgrowth [Balemans et al. 2001], a deletion downstream of this gene, which causes reduced SOST expression, is associated with a milder form of the disorder…”
BackgroundGlucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Reginster, J. Y., Seeman, E., De Vernejoul, M. C., Adami, S., Compston, J., Phenekos, C., Devogelaer, J. P., Curiel, M. D., Sawicki, A., Goemaere, S., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1774 · Cited by 1,071
Effects of weight and body mass index on bone mineral density in men and women: The framingham study
Felson, D. T., Zhang, Y., Hannan, M. T., & Anderson, J. J. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080507 · Cited by 987
Alendronate for the Treatment of Osteoporosis in Men
Orwoll, E., Ettinger, M., Weiss, S., Miller, P., Kendler, D., Graham, J., Adami, S., Weber, K., Lorenc, R., Pietschmann, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430902 · Cited by 973
Mechanisms of Disease: is osteoporosis the obesity of bone?
Rosen, C. J., & Bouxsein, M. L. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0070 · Cited by 956
Li, X., Ominsky, M. S., Niu, Q.-T., Sun, N., Daugherty, B., D'Agostin, D., Kurahara, C., Gao, Y., Cao, J., Gong, J., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080216 · Cited by 936
Khosla, S., Amin, S., & Orwoll, E. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0002 · Cited by 930
Riggs, B. L., Melton, L. J., Robb, R. A., Camp, J. J., Atkinson, E. J., Peterson, J. M., Rouleau, P. A., McCollough, C. H., Bouxsein, M. L., & Khosla, S. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040916 · Cited by 925 · cited 1×
“Large decreases in lumbar spine volumetric BMD (vBMD) secondary to predominant vertebral trabecular bone loss beginning in the third decade and linear decrease in cortical vBMD in the wrist were also demonstrated in both sexes with advancing age [Riggs et al. 2004].”
BackgroundTeriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914
Pathogenesis of bone fragility in women and men
Seeman, E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08706-8 · Cited by 909
Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton
Canalis, E., Economides, A. N., & Gazzerro, E. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0023 · Cited by 863
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis
Justesen, J., Stenderup, K., Ebbesen, E. N., Mosekilde, L., Steiniche, T., & Kassem, M. (2001) · Biogerontology · doi:10.1023/a:1011513223894 · Cited by 840
Physical plasticity of the nucleus in stem cell differentiation
Pajerowski, J. D., Dahl, K. N., Zhong, F. L., Sammak, P. J., & Discher, D. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702576104 · Cited by 833
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W. J., Lacey, D. L., & Riggs, B. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17215 · Cited by 825 · cited 1×
“In vitro and in vivo studies have also shown that estrogen suppresses RANKL production by osteoblastic cells and T and B lymphocytes [Eghbali-Fatourechi et al. 2003; Clowes et al. 2005].”
BackgroundEstrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., & Boyce, B. F. (1996) · Nature Medicine · doi:10.1038/nm1096-1132 · Cited by 813 · cited 1×
“Usually, estrogen may inhibit osteoclast formation and activity by increasing the production of osteoprotegerin (OPG), or transforming growth factor b (TGF-b) [Hofbauer et al. 1999; Hughes et al. 1996].”
BackgroundSingle-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
Padhi, D., Jang, G., Stouch, B., Fang, L., & Posvar, E. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.173 · Cited by 786
Zhou, S., Greenberger, J. S., Epperly, M. W., Goff, J. P., Adler, C., LeBoff, M. S., & Glowacki, J. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00377.x · Cited by 785
Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081206 · Cited by 784
MEUNIER, P., AARON, J., EDOUARD, C., & VlGNON, G. (1971) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-197110000-00021 · Cited by 779
Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757 · cited 2×
“Further studies looking at differential effects between estrogen and testosterone confirmed that estrogen deficiency was more important than testosterone deficiency in causation of bone loss in aging men [Falahati-Nini et al. 2000; Leder et al. 2003] and that the effects of estrogen on bone were independent of FSH [Sa…”
BackgroundThomas, T., Gori, F., Khosla, S., Jensen, M. D., Burguera, B., & Riggs, B. L. (1999) · Endocrinology · doi:10.1210/endo.140.4.6637 · Cited by 726
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F. G., Hildering, P., Willems, P. J., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.2.91 · Cited by 698 · cited 2×
“…bone overgrowth [Balemans et al. 2001], a deletion downstream of this gene, which causes reduced SOST expression, is associated with a milder form of the disorder called van Buchem disease [Balemans et al. 2002] and finally SOST-null mice have a high bone mass phenotype [Li et al. 2008].”
BackgroundHofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Spelsberg, T. C., & Riggs, B. L. (1999) · Endocrinology · doi:10.1210/endo.140.9.7131 · Cited by 692 · cited 1×
“Usually, estrogen may inhibit osteoclast formation and activity by increasing the production of osteoprotegerin (OPG), or transforming growth factor b (TGF-b) [Hofbauer et al. 1999; Hughes et al. 1996].”
BackgroundEFFECT OF RISEDRONATE ON THE RISK OF HIP FRACTURE IN ELDERLY WOMEN
Lung, R. M. C. C., Eusens, P. I. G., Aul, P., Iller, D. M., Ippel, H. A. Z., Ensen, W. I. G. B., Oux, C. H. R., Dami, S. I. A., Ogelman, I. G. F., Astell, R. I. E., et al. (2001) · Cited by 682
Yadav, V. K., Oury, F., Suda, N., Liu, Z.-W., Gao, X.-B., Confavreux, C., Klemenhagen, K. C., Tanaka, K. F., Gingrich, J. A., Guo, X. E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.06.051 · Cited by 661
Lin, C., Jiang, X., Dai, Z., Guo, X., Weng, T., Wang, J., Li, Y., Feng, G., Gao, X., & He, L. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090411 · Cited by 628
Reid, D. M., Hughes, R. A., Laan, R. F. J. M., Sacco-Gibson, N. A., Wenderoth, D. H., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 592
Wolff, I., van Croonenborg, J. J., Kemper, H. C. G., Kostense, P. J., & Twisk, J. W. R. (1999) · Osteoporosis International · doi:10.1007/s001980050109 · Cited by 589
Reeve, J., Meunier, P. J., Parsons, J. A., Bernat, M., Bijvoet, O. L., Courpron, P., Edouard, C., Klenerman, L., Neer, R. M., Renier, J. C., et al. (1980) · BMJ · doi:10.1136/bmj.280.6228.1340 · Cited by 582
Reid, D. M., Devogelaer, J.-P., Saag, K., Roux, C., Lau, C.-S., Reginster, J.-Y., Papanastasiou, P., Ferreira, A., Hartl, F., Fashola, T., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60250-6 · Cited by 527
Khosla, S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3555 · Cited by 522 · cited 1×
“A combination of crosssectional and observational studies of aging men showed better correlations between serum estradiol and BMD than testosterone and BMD at various skeletal sites [Slemenda et al. 1997; Khosla et al. 2001, 2008b; Mellstrom et al. 2008; Szulc et al. 2001].”
BackgroundPPAR-γ regulates osteoclastogenesis in mice
Wan, Y., Chong, L.-W., & Evans, R. M. (2007) · Nature Medicine · doi:10.1038/nm1672 · Cited by 517
Wells, G. A., Cranney, A., Peterson, J., Boucher, M., Shea, B., Welch, V., Coyle, D., & Tugwell, P. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003376.pub3 · Cited by 499
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro
Canalis, E. (1996) · Bone · doi:10.1016/8756-3282(96)00080-4 · Cited by 498
Gimble, J. M., Zvonic, S., Floyd, Z. E., Kassem, M., & Nuttall, M. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20777 · Cited by 495
Slemenda, C. W., Longcope, C., Zhou, L., Hui, S. L., Peacock, M., & Johnston, C. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119701 · Cited by 455 · cited 1×
“A combination of crosssectional and observational studies of aging men showed better correlations between serum estradiol and BMD than testosterone and BMD at various skeletal sites [Slemenda et al. 1997; Khosla et al. 2001, 2008b; Mellstrom et al. 2008; Szulc et al. 2001].”
BackgroundGriffith, J. F., Yeung, D. K. W., Antonio, G. E., Lee, F. K. H., Hong, A. W. L., Wong, S. Y. S., Lau, E. M. C., & Leung, P. C. (2005) · Radiology · doi:10.1148/radiol.2363041425 · Cited by 440
Greenspan, S. L., Bone, H. G., Ettinger, M. P., Hanley, D. A., Lindsay, R., Zanchetta, J. R., Blosch, C. M., Mathisen, A. L., Morris, S. A., Marriott, T. B., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00005 · Cited by 427
Vitamin D status and nutrition in Europe and Asia
Lips, P. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.076 · Cited by 426
Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis
Verma, S., Rajaratnam, J. H., Denton, J., Hoyland, J. A., & Byers, R. J. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.9.693 · Cited by 424
Bisphosphonates: From Bench to Bedside
RUSSELL, R. G. G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.041 · Cited by 410
Pathophysiology of Age-Related Bone Loss and Osteoporosis
Khosla, S., & Riggs, B. L. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.009 · Cited by 376 · cited 1×
“The above opposing processes are consistent with longitudinal and cross-sectional studies which showed a relatively slow rate of decline in areal bone mineral density (aBMD) in both sexes beginning at age 40 and continuing throughout the adult life [Khosla and Riggs, 2005].”
ResultA progeroid syndrome in mice is caused by defects in A-type lamins
Mounkes, L. C., Kozlov, S., Hernandez, L., Sullivan, T., & Stewart, C. L. (2003) · Nature · doi:10.1038/nature01631 · Cited by 367
Greenspan, S. L., Bone, H. G., Ettinger, M. P., Hanley, D. A., Lindsay, R. S., Zanchetta, J., Blosch, C. M., Mathisen, A. L., Morris, S. A., & Marriott, T. B. (2007) · Annals of Internal Medicine · Cited by 360
The role of the immune system in the pathophysiology of osteoporosis
Clowes, J. A., Riggs, B. L., & Khosla, S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00334.x · Cited by 359
Marrow Fat and the Bone Microenvironment: Developmental, Functional, and Pathological Implications
Rosen, C. J., Ackert-Bicknell, C., Rodriguez, J. P., & Pino, A. M. (2009) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v19.i2.20 · Cited by 353
Kaneko, H., Arakawa, T., Mano, H., Kaneda, T., Ogasawara, A., Nakagawa, M., Toyama, Y., Yabe, Y., Kumegawa, M., & Hakeda, Y. (2000) · Bone · doi:10.1016/s8756-3282(00)00358-6 · Cited by 348
Relationship between body composition and bone mass in women
Khosla, S., Atkinson, E. J., Riggs, B. L., & Melton, L. J. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110618 · Cited by 341
Bone, H. G., McClung, M. R., Roux, C., Recker, R. R., Eisman, J. A., Verbruggen, N., Hustad, C. M., DaSilva, C., Santora, A. C., & Ince, B. A. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091035 · Cited by 335
Kaufman, J.-M., Orwoll, E., Goemaere, S., San Martin, J., Hossain, A., Dalsky, G. P., Lindsay, R., & Mitlak, B. H. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1713-3 · Cited by 320
From Density to Structure: Growing Up and Growing Old on the Surfaces of Bone
Seeman, E. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.4.509 · Cited by 302
Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged Bone
Lazarenko, O. P., Rzonca, S. O., Hogue, W. R., Swain, F. L., Suva, L. J., & Lecka-Czernik, B. (2007) · Endocrinology · doi:10.1210/en.2006-1587 · Cited by 302
The role of cathepsins in osteoporosis and arthritis: Rationale for the design of new therapeutics
YASUDA, Y., KALETA, J., & BROMME, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.013 · Cited by 300
Slemenda, C., Longcope, C., Peacock, M., Hui, S., & Johnston, C. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118382 · Cited by 299
Weinreb, M., Rodan, G. A., & Thompson, D. D. (1989) · Bone · doi:10.1016/8756-3282(89)90052-5 · Cited by 289
Differential Effects of Androgens and Estrogens on Bone Turnover in Normal Men
Leder, B. Z., LeBlanc, K. M., Schoenfeld, D. A., Eastell, R., & Finkelstein, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021036 · Cited by 283 · cited 2×
“Further studies looking at differential effects between estrogen and testosterone confirmed that estrogen deficiency was more important than testosterone deficiency in causation of bone loss in aging men [Falahati-Nini et al. 2000; Leder et al. 2003] and that the effects of estrogen on bone were independent of FSH [Sa…”
BackgroundOlder Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures
Mellström, D., Vandenput, L., Mallmin, H., Holmberg, A. H., Lorentzon, M., Odén, A., Johansson, H., Orwoll, E. S., Labrie, F., Karlsson, M. K., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080518 · Cited by 279
Shen, W., Chen, J., Punyanitya, M., Shapses, S., Heshka, S., & Heymsfield, S. B. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0285-9 · Cited by 253
In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation
Baron, R., & Tsouderos, Y. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02040-x · Cited by 251
Osteoblasts play key roles in the mechanisms of action of strontium ranelate
Brennan, T., Rybchyn, M., Green, W., Atwa, S., Conigrave, A., & Mason, R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00305.x · Cited by 248
Khosla, S., Atkinson, E. J., Melton, L. J., & Riggs, B. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3946 · Cited by 247
Eisman, J. A., Bone, H. G., Hosking, D. J., McClung, M. R., Reid, I. R., Rizzoli, R., Resch, H., Verbruggen, N., Hustad, C. M., DaSilva, C., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.212 · Cited by 244
LeBlanc, E. S., Nielson, C. M., Marshall, L. M., Lapidus, J. A., Barrett-Connor, E., Ensrud, K. E., Hoffman, A. R., Laughlin, G., Ohlsson, C., Orwoll, E. S., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0206 · Cited by 240 · cited 2×
“…study of older men again showed a low bio-available estradiol level to be associated with significant increased fracture risk and that testosterone in the presence of high SHBG is associated with significant increased fracture risk when adjusted for estradiol levels [LeBlanc et al. 2009].”
BackgroundCharatcharoenwitthaya, N., Khosla, S., Atkinson, E. J., McCready, L. K., & Riggs, B. L. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070207 · Cited by 235
Insulin-like Growth Factors and Bone: The Osteoporosis Connection
Rosen, C. J., Donahue, L. R., & Hunter, S. J. (1994) · Experimental Biology and Medicine · doi:10.3181/00379727-206-43726 · Cited by 226
Bone mass and body composition in normal women
Lindsay, R., Cosman, F., Herrington, B. S., & Himmelstein, S. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070109 · Cited by 223
Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures
Meikle, A. W. (2009) · Yearbook of Medicine · doi:10.1016/s0084-3873(09)79465-9 · Cited by 222
Clarke, B. L., & Khosla, S. (2010) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2010.02.014 · Cited by 221
S 12911-2 Inhibits Osteoclastic Bone Resorption In Vitro
Takahashi, N., Sasaki, T., Tsouderos, Y., & Suda, T. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.1082 · Cited by 216
A-type lamins: Guardians of the soma?
Hutchison, C. J., & Worman, H. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1062 · Cited by 208
Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.
Oursler, M. J., Pederson, L., Fitzpatrick, L., Riggs, B. L., & Spelsberg, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5227 · Cited by 201
Atkins, G. J., Welldon, K. J., Halbout, P., & Findlay, D. M. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0728-6 · Cited by 200
Eastell, R., Yergey, A. L., Vieira, N. E., Cedel, S. L., Kumar, R., & Dr. Riggs, B. L. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060205 · Cited by 199
Skeletal consequences of thiazolidinedione therapy
Grey, A. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0477-y · Cited by 198
Understanding the Mechanisms of Senile Osteoporosis: New Facts for a Major Geriatric Syndrome
Duque, G., & Troen, B. R. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01764.x · Cited by 183
Self-citationThe role of cathepsin K in normal bone resorption
Troen, B. R. (2004) · Drug News & Perspectives · doi:10.1358/dnp.2004.17.1.829022 · Cited by 176
Khosla, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1740 · Cited by 174
Bioavailable Estradiol May Be an Important Determinant of Osteoporosis in Men: The MINOS Study
Szulc, P. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.192 · Cited by 169
Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice
Duque, G., Huang, D. C., Dion, N., Macoritto, M., Rivas, D., Li, W., Yang, X. F., Li, J., Lian, J., Marino, F. T., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.350 · Cited by 167
Self-citationAlendronate Has an Anabolic Effect on Bone Through the Differentiation of Mesenchymal Stem Cells
Duque, G., & Rivas, D. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070701 · Cited by 156
Self-citationStoch, S. A., Zajic, S., Stone, J., Miller, D. L., Van Dyck, K., Gutierrez, M. J., De Decker, M., Liu, L., Liu, Q., Scott, B. B., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.60 · Cited by 156
Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption
Ledger, G. A. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3304 · Cited by 152
Raisz, L. G., & Rodan, G. A. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00055-5 · Cited by 151
Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density
Glauber, H. S. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1118 · Cited by 144
Influence of mature adipocytes on osteoblast proliferation in human primary cocultures
Maurin, A., Chavassieux, P., Frappart, L., Delmas, P. D., Serre, C., & Meunier, P. J. (2000) · Bone · doi:10.1016/s8756-3282(00)00252-0 · Cited by 143
Akune, T., Ogata, N., Hoshi, K., Kubota, N., Terauchi, Y., Tobe, K., Takagi, H., Azuma, Y., Kadowaki, T., Nakamura, K., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204046 · Cited by 141
Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years
Reginster, J., Bruyère, O., Sawicki, A., Roces-Varela, A., Fardellone, P., Roberts, A., & Devogelaer, J.-P. (2009) · Bone · doi:10.1016/j.bone.2009.08.004 · Cited by 139
Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo
Shi, Y., Yadav, V. K., Suda, N., Liu, X. S., Guo, X. E., Myers, M. G., & Karsenty, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808701106 · Cited by 136
Pycnodysostosis: Role and Regulation of Cathepsin K in Osteoclast Function and Human Disease
Motyckova, G., & Fisher, D. (2002) · Current Molecular Medicine · doi:10.2174/1566524023362401 · Cited by 132
The Regulation of Cathepsin K Gene Expression
TROEN, B. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.018 · Cited by 125
Shalhoub, V., Faust, J., Boyle, W. J., Dunstan, C. R., Kelley, M., Kaufman, S., Scully, S., Van, G., & Lacey, D. L. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990201)72:2<251::aid-jcb9>3.0.co;2-w · Cited by 123
Boonen, S., Mohan, S., Dequeker, J., Aerssens, J., Vanderschueren, D., Verbeke, G., Broos, P., Bouillon, R., & Baylink, D. J. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.12.2150 · Cited by 118
Inhibition of PPARγ prevents type I diabetic bone marrow adiposity but not bone loss
Botolin, S., & McCabe, L. R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20804 · Cited by 115
Marini, J. C., Hopkins, E., Glorieux, F. H., Chrousos, G. P., Reynolds, J. C., Gundberg, C. M., & Reing, C. M. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.237 · Cited by 115
Perrien, D. S., Achenbach, S. J., Bledsoe, S. E., Walser, B., Suva, L. J., Khosla, S., & Gaddy, D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2423 · Cited by 107
Relation of serum serotonin levels to bone density and structural parameters in women
Mödder, U. I., Achenbach, S. J., Amin, S., Riggs, B. L., Melton, L. J., & Khosla, S. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090721 · Cited by 105
Oxygen Sensing and Osteogenesis
Wang, Y., Wan, C., Gilbert, S. R., & Clemens, T. L. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.049 · Cited by 103
Khosla, S., Riggs, B. L., Robb, R. A., Camp, J. J., Achenbach, S. J., Oberg, A. L., Rouleau, P. A., & Melton, L. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0396 · Cited by 98
Causes of Age-Related Bone Loss and Bone Fragility: An Alternative View
Raisz, L. G., & Seeman, E. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.11.1948 · Cited by 95
Lundberg, P., Lundgren, I., Mukohyama, H., Lehenkari, P. P., Horton, M. A., & Lerner, U. H. (2001) · Endocrinology · doi:10.1210/endo.142.1.7912 · Cited by 85
Gain in mass density of bone following strenuous physical activity
Leichter, I., Simkin, A., Margulies, J. Y., Bivas, A., Steinberg, R., Giladi, M., & Milgrom, C. (1989) · Journal of Orthopaedic Research · doi:10.1002/jor.1100070112 · Cited by 80
Khosla, S., Amin, S., Singh, R., Atkinson, E. J., Melton, L. J., & Riggs, B. L. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0591-5 · Cited by 80
Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor
Mitnick, M. A., Grey, A., Masiukiewicz, U., Bartkiewicz, M., Rios-Velez, L., Friedman, S., Xu, L., Horowitz, M. C., & Insogna, K. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.3.e405 · Cited by 78
Decreased Bone Formation and Osteopenia in Lamin A/C-Deficient Mice
Li, W., Yeo, L. S., Vidal, C., McCorquodale, T., Herrmann, M., Fatkin, D., & Duque, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019313 · Cited by 76
Self-citationHigh Serum IGFBP-2 Is Predictive of Increased Bone Turnover in Aging Men and Women
Amin, S., Riggs, B. L., Melton, L. J., Achenbach, S. J., Atkinson, E. J., & Khosla, S. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070306 · Cited by 69
Aging alters the skeletal response to disuse in the rat
Perrien, D. S., Akel, N. S., Dupont‐Versteegden, E. E., Skinner, R. A., Siegel, E. R., Suva, L. J., & Gaddy, D. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00302.2006 · Cited by 68
Age-related bone loss in the LOU/c rat model of healthy ageing
Duque, G., Rivas, D., Li, W., Li, A., Henderson, J. E., Ferland, G., & Gaudreau, P. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.10.004 · Cited by 67
Self-citationNguyen, T. V., Pocock, N. A., & Eisman, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030551 · Cited by 61
Marie, P. J. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.3.824 · Cited by 57
Duque, G., & Rivas, D. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.12.007 · Cited by 56
Self-citationNeuro-hormonal control of bone metabolism:
Lundberg, P., Boström, I. M., Mukohyama, H., Bjurholm, A., Smans, K. A., & Lerner, U. H. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00069-5 · Cited by 51
Accelerated Features of Age-Related Bone Loss in Zmpste24 Metalloproteinase-Deficient Mice
Rivas, J. D. L., Li, W., Akter, R., Henderson, J. E., & Duque, G. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp089 · Cited by 51
Self-citationRegulation of Bone Turnover by Sex Steroids in Men
Sanyal, A., Hoey, K. A., Mödder, U. I., Lamsam, J., McCready, L. K., Peterson, J. M., Achenbach, S. J., Oursler, M. J., & Khosla, S. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071212 · Cited by 42
McCauley, L. K., Tözüm, T. F., Kozloff, K. M., Koh-Paige, A. J., Chen, C., Demashkieh, M., Cronovich, H., Richard, V., Keller, E. T., Rosol, T. J., et al. (2003) · Connective Tissue Research · doi:10.1080/03008200390181744 · Cited by 33
Medical Treatment of Osteoporotic Vertebral Fractures
Langdahl, B. L., & Harsløf, T. (2011) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x10392105 · Cited by 31
Lane, N. E., & Silverman, S. L. (2010) · Current Osteoporosis Reports · doi:10.1007/s11914-010-0005-4 · Cited by 31
Musacchio, E., Priante, G., Budakovic, A., & Baggio, B. (2007) · Connective Tissue Research · doi:10.1080/03008200601056528 · Cited by 29
As a matter of fat: New perspectives on the understanding of age-related bone loss
Duque, G. (2007) · BoneKEy-Osteovision · doi:10.1138/20070257 · Cited by 24
Self-citationRole of parathyroid hormone in mediating age-related changes in bone resorption in men
Kennel, K. A., Riggs, B. L., Achenbach, S. J., Oberg, A. L., & Khosla, S. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1417-0 · Cited by 24
The promise of sclerostin inhibition for the treatment of osteoporosis
Kneissel, M. (2009) · IBMS BoneKEy · doi:10.1138/20090388 · Cited by 20
Lecka‐Czernik, B. (2006) · PPAR Research · doi:10.1155/ppar/2006/18089 · Cited by 17
Pfeilschifter, J., Diel, I., Klöppinger, T., Bismar, H., Schuster, E. M., Balbach, S., Ziegler, R., Baylink, D. J., & Mohan, S. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00132-9 · Cited by 16
Attenuated anabolic response to exercise in lamin A/C haploinsufficient mice
Duque, G., Li, W., Yeo, L. S., Vidal, C., & Fatkin, D. (2011) · Bone · doi:10.1016/j.bone.2011.04.023 · Cited by 16
Self-citationWarrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Cited by
Immunology of Osteoporosis: A Mini-Review
Pietschmann, P., Mechtcheriakova, D., Meshcheryakova, A., Föger-Samwald, U., & Ellinger, I. (2016) · Gerontology · doi:10.1159/000431091 · Cited by 287
Aging, inflammation, immunity and periodontal disease
Ebersole, J. L., Graves, C. L., Gonzalez, O. A., Dawson, D., Morford, L. A., Huja, P. E., Hartsfield, J. K., Huja, S. S., Pandruvada, S., & Wallet, S. M. (2016) · Periodontology 2000 · doi:10.1111/prd.12135 · Cited by 278
Obesity and Bone: A Complex Relationship
Rinonapoli, G., Pace, V., Ruggiero, C., Ceccarini, P., Bisaccia, M., Meccariello, L., & Caraffa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413662 · Cited by 261
FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging
Li, H., Liu, P., Xu, S., Li, Y., Dekker, J. D., Li, B., Fan, Y., Zhang, Z., Hong, Y., Yang, G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89511 · Cited by 180
TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis
Li, J., Ayoub, A., Xiu, Y., Yin, X., Sanders, J. O., Mesfin, A., Xing, L., Yao, Z., & Boyce, B. F. (2019) · Nature Communications · doi:10.1038/s41467-019-10677-0 · Cited by 86
Metadata
- Authors
- Demontiero, O., Vidal, C., & Duque, G.
- Venue
- Therapeutic Advances in Musculoskeletal Disease
- Publisher
- SAGE Publications
- Published
- 2011-12-14
- Volume
- 4
- Issue
- 2
- Pages
- 61-76
- ISSN
- 1759-720X (ISSN-L)
- 1759-7218
- OpenAlex
- W2068613829
- Cited by
- 559
- References
- 146
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.